Eli Lilly disclosed in an SEC filing that Nobel laureate Carolyn Bertozzi will rejoin the company’s board of directors on Dec. 8. Bertozzi, who won the 2022 Nobel Prize in Chemistry, brings high‑profile expertise in glycobiology and bioorthogonal chemistry to Lilly’s governance and R&D oversight. Her return reinforces Lilly’s engagement with leading academic scientists as the company expands innovation across modalities including biologics and targeted therapies.